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Rabbit Haemorrhagic Disease (RHD) is caused by a calicivirus (RHDV) that kills 90% of infected adult European
rabbits within 3 days. Remarkably, young rabbits are resistant to RHD. We induced immunosuppression in young
rabbits by treatment with methylprednisolone acetate (MPA) and challenged the animals with RHDV by
intramuscular injection. All of these young rabbits died within 3 days of infection due to fulminant hepatitis,
presenting a large number of RHDV-positive dead or apoptotic hepatocytes, and a significant seric increase in
cytokines, features that are similar to those of naïve adult rabbits infected by RHDV. We conclude that MPA-induced
immunosuppression abrogates the resistance of young rabbits to RHD, indicating that there are differences in the
innate immune system between young and adult rabbits that contribute to their distinct resistance/susceptibility to
RHDV infection.Introduction, methods and results
Rabbits of the species Oryctolagus cuniculus are the
natural hosts of the Rabbit Haemorrhagic Disease Virus
(RHDV). This virus targets the liver of rabbits and causes
the death of millions of wild and domestic adult rabbits
worldwide [1-3]. Usually, adult rabbits die within 3 days of
RHDV infection as a result of fulminant hepatitis, showing
no symptoms of the disease until a few hours before death.
Interestingly, young rabbits (less than 4 weeks-old) are
resistant to Rabbit Haemorrhagic Disease (RHD), devel-
oping only a sub-clinical disease to the viral infection
[3-6]. A central issue in the pathogenesis of RHD is to
understand this age-related resistance to a viral infec-
tion that is fatal in adult animals. Pertinent to this issue,
Ruvoën-Clouet et al. [7] reported that RHDV is capable
of binding to histo-blood group antigens (HBGA) that
are expressed on the mucosa of the upper respiratory
and digestive tracts of adult rabbits, and they have pos-
tulated that the density of these attachment factors on
mucosal cells is essential for adult rabbits to be suscep-
tible to RHDV infection. In agreement with their view,
they found only a weak binding of virus particles to the* Correspondence: ramarques@icbas.up.pt
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reproduction in any medium, provided the orsame mucosal tissues in young rabbits, thus indicating
that low expression of HBGA could explain the resistance
of young animals to RHD. Nevertheless, and despite this
evidence, they recently reported that low expression of
these facilitating factors of the infection, at the epithelial
level, only confers partial protection against RHDV infec-
tion [3,8]. They also showed that hepatocytes, the main
target of RHDV replication, do not express HBGA [7,8],
which led them to suggest the existence of additional hep-
atic cellular receptor(s) for the virus [3]. Additionally, we
demonstrated that young rabbits infected with RHDV by
the intramuscular route develop the exact same mild liver
disease that we had observed in young rabbits infected
with RHDV by natural, oral and nasal routes [4,9-12]. This
made us consider that resistance of young rabbits to RHD
may depend on additional putative factors. A difference
in innate immunity is one of these possible factors,
since previous data have shown that young and adult
rabbits develop different immune responses after RHDV
infection [4-6,13-16]. Thus, we decided to study whether
altering the immune physiology of young rabbits by meth-
ylprednisolone acetate (MPA)-induced immunosuppres-
sion would interfere with the resistance of young rabbits
to RHDV infection.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were used when the animals were 4 weeks old. The rab-
bits were kept under standard conditions of housing
with unrestricted access to food and water; this was
done according to the European Union Directive no.
2010/63/CE and was approved by the appropriate local
ethic committee (“Comité de Ética do ICBAS/UP”). The
inoculum of RHDV (Ast/89 strain) was obtained as pre-
viously described by Teixeira et al. [17] and had a 210
titre in haemagglutination units (HAU). Fourteen young
rabbits (24 days) were immunosuppressed with an intra-
muscular injection of a suspension of MPA a long-acting
corticosteroid (Depo-Medrol®; 20 mg/kg). All animals
were also injected subcutaneously with a broad spectrum
antibiotic, enrofloxacine (Alsir® 2.5%; 10 mg/kg), in order
to prevent secondary bacterial infections. One week later,
9 of the 14 immunosuppressed rabbits were challenged
with 100 μL of RHDV injected intramuscularly. The other
5 young rabbits were used as controls of the immunosup-
pression, i.e. they were euthanized and their thymuses
were collected and weighed in relation with the body
weight of the rabbits [18]. Another group of 15 young
rabbits were used as the control of the infection or of
the experiment. Ten animals were inoculated, injected
intramuscularly, with 100 μL of RHDV, and the other 5
were inoculated, injected intramuscularly, with 100 μL
of PBS, at the same time of the immunosuppressed
rabbits. Five of the infected rabbits also received the
antibiotic, according to the same scheme of the immuno-
suppressed rabbits. All the animals were observed regu-
larly, and clinical manifestations of RHD were monitored.
After the animal’s death, by disease or euthanasia (as de-
scribed by Marques et al. [16]), the presence of macro-
scopic lesions compatible with RHD was investigated.
Fragments of the thymus, spleen and liver were collected
for histopathological and TUNEL analysis as described
below. Blood samples were obtained from the vena cava
caudal in order to quantify the seric level of cytokines
(TNF-α, IL-6 and IL-10) by ELISA (ELISA Kit, Uscn
Life Science Inc., Wuhan, People’s Republic of China)
in 3 of the experimental groups: PBS control rabbits,
immunosuppressed rabbits and immunosuppressed,
RHDV-infected young rabbits. Liver samples of im-
munosuppressed, RHDV-infected young rabbits and in-
fected young rabbits were also collected to quantify the
presence of RHDV antigen by ELISA (the viral titer corre-
sponding to the threshold value of dilution at which the
sample is considered positive to RHDV, i.e., when its value
is superior to the calculated cut-off (0.2 ×OD405nm posi-
tive control sample; INGEZIM RHDV 17.RHD.K2 kit,
Ingenasa, Madrid, Spain). Other liver samples were fixed
by 10% buffered formalin, dehydrated through graded
alcohols and xylene and embedded in paraffin wax by
standard methods. These were used for light microscopystudies that included immunocytochemistry for RHDV
antigen (protocol described by Marques et al. [16]) and
TUNEL assay for apoptosis detection (protocol described
according to the manufacturer’s instructions (TdT in
situ - DAB In Situ Apoptosis Detection Kit, R&D Systems
Europe, Ltd., Abingdon, United Kingdom)). Samples of
the spleen and thymus were also fixed with 10% buffered
formalin to be used for apoptosis detection by the TUNEL
assay. Statistical comparison of data from all groups of
rabbits was performed using an unpaired t-test calculated
with GraphPad Prism, version 5.0a, software. Differences
were considered significant at p < 0.05.
All immunosuppressed, RHDV-infected young rabbits
died within 24–72 h of RHDV infection (24–30 h n = 2;
36–48 h n = 6; 60–72 h n = 1) depicting the hyperacute
form of RHD, i.e., they died suddenly, often without con-
spicuous signs of disease, showing prostration, lethargy
and anorexia. As expected, all non-immunosuppressed
infected young rabbits showed no clinical symptoms of
disease after being infected with RHDV; they were eu-
thanized 1 week after the viral inoculation. Immunosup-
pressed rabbits (infected (IS + I) or not (IS)) showed
atrophic thymuses, indicating that immunosuppression
had been achieved; this atrophy was confirmed by
the ratio thymus (g)/body weight (g) since we found
that these ratios were significantly lower in immuno-
suppressed groups (IS group: 0.00048 ± 0.000049; IS + I
group: 0.00054 ± 0.000050; mean ± standard error of the
mean (SEM); p < 0.0001) than in control rabbits (PBS
group: 0.0024 ± 0.00024; mean ± SEM). The immuno-
suppressed, RHDV-infected young rabbits showed the
typical lesions of RHD, such as enlarged and pale livers
with enhanced lobular patterns, congestion and haem-
orrhagic lesions of several viscera, and bloody foam
in the trachea. A significant difference was seen in
the spleen volume, with splenomegaly in immunosup-
pressed, RHDV-infected rabbits in contrast with spleen
atrophy in immunosuppressed animals (ratio - spleen
(g)/body weight (g); p < 0.05). Young rabbits that were
infected with RHDV did not present any macroscopic
lesions suggestive of RHD, 7 days after the viral inocula-
tion, when they were euthanized. Widespread liver cell
vacuolization was seen in immunosuppressed, RHDV-
infected young rabbits; these hepatocytes often showed
pyknotic nuclei and karyorrhexis, classic features of cell
death (Figure 1A). The TUNEL assay confirmed exten-
sive cell death of hepatocytes and this was illustrated by
brown-nuclear staining (early apoptotic cells) or brown-
cytoplasmic staining (late apoptotic or necrotic cells)
(Figure 2A). Scattered inflammatory cells (predomin-
antly heterophils) were seen in the liver of the animals.
In contrast, hepatic tissue of the immunosuppressed rab-
bits did not reveal any signs of hepatocellular degeneration
suggestive of apoptosis. In RHDV-infected young rabbits,
Figure 1 Immunocytochemistry of RHDV antigen in the liver. A: Light micrograph of a liver paraffin section of an immunosuppressed,
RHDV-infected young rabbit that died with RHD showing widespread positive immunodetection of the major RHDV antigen (brown staining).
Heterophils are observed surrounding the damaged hepatocytes and inside sinusoids (arrows). The tissue section was labelled with an anti-VP60
mouse antiserum; haematoxylin counterstain; bar = 100 μm. B: A liver section of an immunosuppressed, RHDV-infected young rabbit that died
with RHD and that was labeled with control mouse antiserum; haematoxylin counterstain, bar = 100 μm. C: A liver paraffin section of an infected
young rabbit that survived the infection and was euthanized 7 days later. Signs of hepatocellular regeneration are visible as expressed by
enlarged and often binucleated cells (without the formation of organized hepatic cords); some tissue spaces are occupied by small basophilic
cells, with an oval shape, that are suggestive of hepatocyte precursors. The tissue section was labeled with an anti-VP60 mouse antiserum;
haematoxylin counterstain, bar = 100 μm.
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hepatic regeneration as expressed by rebuilding of focal
hepatic lesions that had been produced by the infection
(Figure 1C). All immunosuppressed, RHDV-infected
young rabbits presented an extensive brown-staining of
the liver for the RHDV antigen (Figure 1A). In contrast,
RHDV-infected young rabbits, euthanized 7 days after
infection, exhibited, in general, no RHDV-positive staining
(Figure 1C). ELISA revealed that all immunosuppressed,
RHDV-infected young rabbits presented elevated viral
titers in the liver (240.0 ± 99.06; mean ± SEM), similarly
to those found in RHDV-infected adult rabbits that died
spontaneously with RHD (170.7 ± 42.67; mean ± SEM;
n = 3; data obtained from previous experiments). In con-
trast, the virus was not detected in the livers of young rab-
bits that had been submitted to the RHDV infection. The
TUNEL assay confirmed marked apoptosis in the thymus
of immunosuppressed, RHDV-infected rabbits and this
was less extensive in the spleen (Figures 2E-F); these tissue
changes were not observed in infected young rabbits notsubmitted to immunosuppression (Figures 2G-H). As
expected, significant apoptosis of thymus lymphocytes
was observed in all immunosuppressed animals (Figure 2D).
The values of the proinflammatory cytokines, TNF-α, IL-6,
and the anti-inflammatory cytokine, IL-10, were deter-
mined in the sera of PBS control rabbits, immunosup-
pressed rabbits and immunosuppressed, RHDV-infected
young rabbits. All cytokines had a marked increase in
the serum of immunosuppressed, RHDV-infected young
rabbits that died with RHD, TNF-α in particular
(Figure 3).
Discussion
RHDV infection kills most adult rabbits, whereas young
rabbits show no disease [4,5,12]. Our previous reports
on the pathogenesis of RHD [5,6,14-16] indicated that
young and adult rabbits may differ in innate immune re-
sponse, since the adult animals usually die in less than 3
days (a too early timing for the host to mount a specific
immune response to the infectious agent). To investigate
Figure 2 Immunocytochemistry of apoptosis in the liver, spleen and thymus. Light micrographs of the liver, spleen and thymus paraffin
sections where the immunodetection of cellular apoptosis was obtained by TUNEL; counterstaining with haematoxylin. In liver sections,
bar = 100 μm; in spleen and thymus sections, bar = 200 μm. A: A liver paraffin section of an immunosuppressed, RHDV-infected young rabbit that
died due to RHD. B: A liver paraffin section of an immunosuppressed, RHDV-infected young rabbit that died from RHD; control of the TUNEL
assay. C: A spleen paraffin section of an immunosuppressed young rabbit euthanized 7 days after immunosuppression. D: A thymus paraffin
section of an immunosuppressed young rabbit euthanized 7 days after immunosuppression. E: A spleen paraffin section of an immunosuppressed,
RHDV-infected young rabbit that died from RHD. F: A thymus paraffin section of an immunosuppressed, RHDV-infected young rabbit that died
from RHD. G: A spleen paraffin section of an infected young rabbit euthanized 7 days after RHDV infection. H: A thymus paraffin section of an
infected young rabbit euthanized 7 days after RHDV infection.
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young rabbits, we decided to investigate whether immuno-
suppression would change the progress of calicivirus infec-
tion in these animals. For that, we studied rabbits treatedwith MPA, a corticosteroid of long-duration, with pleio-
tropic actions including immunosuppression due to in-
hibition of the inflammatory response and depletion of
both T and B cells [19,20].
Figure 3 Evaluation of serum cytokines – graphics. A: Comparison
of TNF-α levels in the serum of control (PBS) young rabbits (n= 5),
immunosuppressed (IS) young rabbits (n = 5), and immunosuppressed
RHDV-infected (IS + I) young rabbits (n = 9) that died from RHD;
unpaired t test, (***p < 0.0001); the results are shown as a mean ±
SEM). B: Comparison of IL-6 levels in the serum of control (PBS)
young rabbits (n = 5), immunosuppressed (IS) young rabbits (n = 5)
and immunosuppressed RHDV-infected (IS + I) young rabbits (n = 9)
that died from RHD; unpaired t test, (*p < 0.05); the results are
shown as a mean ± SEM). C: Comparison of IL-10 levels in the
serum of control (PBS) young rabbits (n = 5), immunosuppressed
(IS) young rabbits (n = 5), and immunosuppressed RHDV-infected
(IS + I) young rabbits (n = 9) that died from RHD; unpaired t test,
(**p < 0.01); the results are shown as a mean ± SEM).
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died from RHDV infection within 3 days, just as naïve
adult rabbits do after RHDV inoculation. The animals died
from fulminant hepatitis that was associated with wide-
spread apoptosis and disseminated intravascular coagula-
tion (DIC). The inflammatory infiltrates in the liver of the
immunosuppressed, RHDV-infected young rabbits were
mainly constituted by heterophils, contrary to what would
be expected in infected young rabbits, i.e., where liver in-
filtrates contain macrophages and lymphocytes [3,4,6].
These features mimic the typical pathology of RHD in
adult rabbits after being infected by RHDV [12,14,21].
Also, similarly to infected adult rabbits, the immunosup-
pressed, RHDV-infected young rabbits showed a marked
dissemination of RHDV throughout the liver. The viral ti-
ters registered in the liver of immunosuppressed, RHDV-
infected young rabbits were also similar to those found in
infected adult rabbits. These data show that young rabbits
that are treated with MPA develop the full blown RHD
seen in adult animals after RHDV infection. This change
of young rabbits from resistance to susceptibility to the
calicivirus is likely to result from impairment of theirinnate immunity, i.e., the MPA treatment could, for ex-
ample, be interfering with the process of antigen presenta-
tion, with the phagocytic activity, or with the effector roles
of activated NK cells, NK T cells or possibly CD8+ T cells
[22-25]. Our results weaken the hypothesis that resistance
of young rabbits to RHD derives from a different expres-
sion of the viral hepatic cellular receptor(s), since the
MPA treatment of the young rabbits made the RHDV cap-
able of infecting the hepatocytes, as observed in adult
rabbits.
We also report here a marked increase in proinflam-
matory and anti-inflammatory cytokines (TNF-α, IL-6
and IL-10) in the serum of the immunosuppressed,
RHDV-infected young rabbits. This enhancement in cy-
tokines is similar to what occurs in the blood of infected
adult rabbits a few hours prior to death. Others have
previously shown that RHDV infection of adult rabbits
is related to a strong increase of mRNA levels of pro-
inflammatory cytokines in the liver, target organ of viral
replication [26,27]. The histopathological signs of ful-
minant hepatitis observed in the immunosuppressed,
RHDV-infected young rabbits, similarly to what hap-
pens in adult rabbits having died from RHD, involved
numerous apoptotic liver cells that are due to the cyto-
pathic effect of viral replication and the exacerbated
inflammatory response caused by the deregulated ex-
pression of cytokines detected in these animals, TNF-α
in particular, since it is a well-known cell death medi-
ator [26,27]. A similar phenomenon is seen in B hepa-
titis, where secretion of TNF-α by macrophages and
infected hepatocytes contributes to liver cell death [28,29].
In contrast, young rabbits that are infected with RHDV
present an early and only mild increase of proinflamma-
tory cytokines [16]. This corroborates the idea that RHDV
infection in young rabbits is associated with an early
and adequate inflammatory immune response that may
be vital in strongly limiting viral replication, and conse-
quently allowing the more than 3 days that are required
for the rabbits to develop a specific immune response
against RHDV, similarly to what is observed in the few
survivors of Ebola virus infection [10,30].
In conclusion, we demonstrate that the innate immune
response of young rabbits is abrogated by the MPA treat-
ment, changing young rabbits into hosts that become as
susceptible to fatal calicivirus infection as naïve adult
rabbits are. Thus we propose that the resistance of
young rabbits to RHDV-infection is mediated by their
particular innate immunity that is different from that of
adult rabbits. Moreover, this discovery opens the way
for a better understanding of the rationale of resistance
of young rabbits to RHD.Competing interests
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